Whitehead Institute scientists have genetically and enzymatically modified red blood cells to carry a range of valuable payloads—from drugs, to vaccines, to imaging agents—for delivery to specific sites throughout the body.
“We wanted to create high-value red cells that do more than simply carry oxygen,” says Whitehead Founding Member Harvey Lodish, who collaborated with Whitehead Member Hidde Ploegh in this pursuit. “Here we’ve laid out the technology to make mouse and human red blood cells in culture that can express what we want and potentially be used for therapeutic or diagnostic purposes.”
Lodish believes the applications are potentially vast and may include RBCs modified to bind and remove bad cholesterol from the bloodstream, carry clot-busting proteins to treat ischemic strokes or deep-vein thrombosis, or deliver anti-inflammatory antibodies to alleviate chronic inflammation.
Read more . . .
The Latest on: Engineered Red Blood Cells
[google_news title=”” keyword=”Engineered Red Blood Cells” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Engineered Red Blood Cells
- Innovative malaria prodrug targets liver, enhances efficacy while reducing toxicity, preclinical studies showon April 23, 2024 at 7:03 am
The prodrug is also engineered to optimize transport through liver cells, aiming to achieve a radical cure with a single dose while minimizing the production of hemotoxic metabolites in the liver.
- Can Your Immune System Be Rejuvenated? Yes, Says New Researchon April 19, 2024 at 11:01 am
As we age, the immune system begins to weaken. This leaves us exposed to dangerous infections. But a new study offers hope: we may soon be able to reverse the trend.
- MIT Technology Reviewon April 12, 2024 at 3:00 am
CAR-T cells could revolutionize the treatment of a wide variety of diseases, if only we can make them cheaper.
- New malaria vaccine strain shows promise in preclinical trialson April 3, 2024 at 12:38 am
In a report published on March 21, 2024 in EMBO Molecular Medicine (A replication competent Plasmodium falciparum parasite completely attenuated by dual gene deletion) investigators at Seattle ...
- Clinical trial: Some sarcoma patients improve with T cell immunotherapyon March 28, 2024 at 8:33 am
The most common side effects of the treatment involved low red and white blood cell counts due to the chemotherapy needed to prepare the body to receive the engineered T cells. Many of the ...
- Blood, sweat, and water: New paper analytical devices easily track health and environmenton March 28, 2024 at 6:53 am
When you need to measure white blood cell counts, it usually involves trips ... in which the paper is engineered with channels and collection zones that measure out defined volumes of blood ...
- How personalized medicine is transforming your health careon October 4, 2023 at 8:52 am
micro-engineered spinal cord tissue from a patient with amyotrophic lateral sclerosis. Motor neurons (white) and a blood vessel (red), derived from the ALS patient’s stem cells, form functioning ...
- Red Light Therapy Offers a Slew of Unexpected Health Benefits, From Healing Cold Sores to Reducing Wrinkleson April 22, 2023 at 2:21 pm
The authors of thousands of published peer-reviewed papers believe that this band of light stimulates the mitochondria in your cells ... s Red Light Therapy Sleep Light is engineered to help ...
- Red Cell Therapeutics: realizing the promise of cellular medicineon March 1, 2022 at 6:05 am
Rubius Therapeutics is a biopharmaceutical company based in Cambridge, Massachusetts, USA, that is developing allogeneic cell therapies based on biologically engineered red blood cells (RBCs).
- School of Biochemistry prize for the best talk by a third year Biochemistry postgraduate studenton November 21, 2019 at 6:31 pm
This work was an important demonstration of the power of gene editing to produce engineered red blood cells. Such cells could one day be used to supplement the blood donation system for patients with ...
via Bing News